Moreover, we focused primarily on inflammatory and hematologic indices; the addition of emerging markers of endothelial dysfunction (e.g., endothelin-1, von Willebrand factor) or systemic inflammation (e.g., interleukin-6, C-reactive protein) may enhance prognostic stratification. The gene discussed is EDN1; the disease is endothelial dysfunction.